TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 7923306

Group type: EXPERIMENTAL
Intervention: Naproxen sodium 440 mg
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Acetaminophen 1000 mg
Number of subjects: 226

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 226
Study: 3074621

Group type: EXPERIMENTAL
Intervention: Cinnarizine
Number of subjects: 908

Group type: EXPERIMENTAL
Intervention: Flunarizine
Number of subjects: 908

Group type: EXPERIMENTAL
Intervention: Bencyclan
Number of subjects: 908

Group type: EXPERIMENTAL
Intervention: Smaller doses of medications
Number of subjects: 908

Group type: COMPARATOR
Intervention: Placebo or other medication
Number of subjects: 908
Study: 29124630

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo Inspiratory Muscle Training (P-IMT)
Number of subjects: 16
Study: 28361654

Group type: EXPERIMENTAL
Intervention: Active play intervention with staff training and 60-minute weekly sessions for 6 weeks
Number of subjects: 162

Group type: COMPARATOR
Intervention: Control group receiving only a resource pack
Number of subjects: 162
Study: 25475110

Group type: EXPERIMENTAL
Intervention: 100 mg alternate-day aspirin
Number of subjects: 27939

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27939
Study: 22033049

Group type: EXPERIMENTAL
Intervention: Simulator-based education (4 hours of training)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditionally trained (control group)
Number of subjects: 60
Study: 20167179

Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 29

Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 29
Study: 17964789

Group type: EXPERIMENTAL
Intervention: Albendazole plus antiepileptic drugs (group A)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Antiepileptic drugs alone (group B)
Number of subjects: 300
Study: 15475605

Group type: EXPERIMENTAL
Intervention: Obese subjects seated
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Obese subjects supine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control subjects supine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Obese subjects seated and supine
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Obese subjects
Number of subjects: 10
Study: 12036523

Group type: EXPERIMENTAL
Intervention: Oral dipyridamole (75 mg twice a day for 5 days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 10219433

Group type: EXPERIMENTAL
Intervention: Nasal massage of the 'yingxiang' acupuncture point for 30 seconds
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group without nasal massage
Number of subjects: 20
Study: 7609566

Group type: EXPERIMENTAL
Intervention: Heparin and protamine dosing according to in vitro predictive tests integrating drugs, tests, and patient response
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conventional methods of heparin and protamine dosing
Number of subjects: 46
Study: 2505717

Group type: EXPERIMENTAL
Intervention: Perindopril
Number of subjects: 34
Study: 24829

Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Corticosteroids combined with an adrenergic beta-stimulant
Number of subjects: 0
Study: 31246607

Group type: EXPERIMENTAL
Intervention: Proximal adductor canal block
Number of subjects: 108

Group type: COMPARATOR
Intervention: Mid adductor canal block
Number of subjects: 108

Group type: COMPARATOR
Intervention: Distal adductor canal block
Number of subjects: 108
Study: 29882510

Group type: EXPERIMENTAL
Intervention: Test formulation (TMPP tablet, 200 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Reference formulation (TMPP tablet, 200 mg)
Number of subjects: 20
Study: 27129086

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Indapamide
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 84
Study: 25223986

Group type: EXPERIMENTAL
Intervention: Metastases-directed therapy (MDT) followed by active surveillance
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active surveillance only
Number of subjects: 0
Study: 23032234

Group type: EXPERIMENTAL
Intervention: Turmeric chips
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Curcumin chips
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional nonsurgical methods
Number of subjects: 0
Study: 20222769

Group type: EXPERIMENTAL
Intervention: Modified constraint-induced movement therapy (CIMT)
Number of subjects: 32
Study: 18585495

Group type: EXPERIMENTAL
Intervention: Benznidazole (5 mg/kg per day) for 60 days
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 3000
Study: 16126045

Group type: EXPERIMENTAL
Intervention: Fluconazole prophylaxis (twice weekly for up to 6 weeks)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Fluconazole prophylaxis (previous dosing schedule)
Number of subjects: 81
Study: 12823779

Group type: EXPERIMENTAL
Intervention: 2‐Chlorodeoxyadenosine (2‐CdA), administered as a single 7‐day course
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BL22, a fusion of an anti‐CD22 antibody linked to a portion of the Pseudomonas exotoxin A
Number of subjects: 0

Group type: COMPARATOR
Intervention: 2‐deoxycoformycin
Number of subjects: 0
Study: 10193737

Group type: EXPERIMENTAL
Intervention: Aspirin (325 mg every other day)
Number of subjects: 14916

Group type: EXPERIMENTAL
Intervention: High fibrinogen levels (>=343 mg/dl)
Number of subjects: 14916

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 14916
Study: 8616992

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 20
Study: 2114029

Group type: EXPERIMENTAL
Intervention: Combination of Rifampicin, Isoniazid, and Pyrazinamide (administered separately or in combined preparations)
Number of subjects: 250
Study: 395310

Group type: EXPERIMENTAL
Intervention: Relaxation procedure
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Proportional biofeedback
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Proportional biofeedback plus criterion information
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (visual feedback display with no instructions)
Number of subjects: 40
Study: 30260676

Group type: EXPERIMENTAL
Intervention: Total etching (TE)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Partial etching (PE)
Number of subjects: 20
Study: 27229727

Group type: COMPARATOR
Intervention: Placebo (without F, CaGP or TMP)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 550 ppm F (550F)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1100 ppm F (1100F)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 550 ppm F with 1% TMP (550F-TMP)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 550 ppm F with 0.25% CaGP (550F-CaGP)
Number of subjects: 12
Study: 26376464

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 44

Group type: COMPARATOR
Intervention: Glimepiride (4 mg)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 44
Study: 23819814

Group type: EXPERIMENTAL
Intervention: T allele and CT+TT genotypes of rs3918242
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Total serum levels of MMP‐9
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: T alleles in the CAD group
Number of subjects: 258

Group type: COMPARATOR
Intervention: Variant genotypes of rs17576
Number of subjects: 258
Study: 21430255

Group type: EXPERIMENTAL
Intervention: 50 g sunflower oil (rich in n-6 PUFA)
Number of subjects: 13

Group type: COMPARATOR
Intervention: 50 g butter (rich in SFA)
Number of subjects: 13
Study: 21499649

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate (0.12%)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sodium fluoride (0.5%)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sodium iodine (2%)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no mouthwash or initial dental treatment)
Number of subjects: 60
Study: 17909953

Group type: EXPERIMENTAL
Intervention: Flebogamma 5% DIF administered at a dose of 300‐600 mg/kg every 21‐28 days for 12 months
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Flebogamma 5% DIF
Number of subjects: 46
Study: 16341485

Group type: EXPERIMENTAL
Intervention: Tension-free hernioplasty
Number of subjects: 106

Group type: COMPARATOR
Intervention: Conventional hernioplasty
Number of subjects: 106
Study: 11934542

Group type: EXPERIMENTAL
Intervention: Very low-energy diet therapy for 4 weeks
Number of subjects: 103

Group type: COMPARATOR
Intervention: Normal-weight subjects (BMI 18.5 < or = BMI < 25.0)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Underweight subjects (BMI < 18.5)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Overweight (25 < or = BMI < 30) and obese subjects (30 < or = BMI < 40, and BMI > or = 40)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Menstrual cycle
Number of subjects: 103
Study: 10747518

Group type: EXPERIMENTAL
Intervention: 20 degrees C
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 28 degrees C
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-cooled group (28 degrees C)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cooled group (20 degrees C)
Number of subjects: 0
Study: 8747844

Group type: EXPERIMENTAL
Intervention: Muscle sympathetic nerve activity (MSNA) in patients with ALS
Number of subjects: 12

Group type: COMPARATOR
Intervention: Muscle sympathetic nerve activity (MSNA) in controls
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Head-up tilting effect on MSNA and blood pressure in ALS patients
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Correlation of MSNA with disability score and other factors in ALS patients
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: MSNA at rest in ALS patients
Number of subjects: 12
Study: 2478368

Group type: EXPERIMENTAL
Intervention: Combined drug therapy (choline-piracetam)
Number of subjects: 0
Study: 795157

Group type: EXPERIMENTAL
Intervention: Dibasole and ascorbic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Glucose (Control)
Number of subjects: 0
Study: 31210019

Group type: EXPERIMENTAL
Intervention: 20 mg subconjunctival injection of triamcinolone acetonide (TA)
Number of subjects: 101

Group type: COMPARATOR
Intervention: 1 mg/ml dexamethasone eye drops (DEX)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Both groups (TA and DEX)
Number of subjects: 101
Study: 31148275

Group type: EXPERIMENTAL
Intervention: Perceptions of technical and strength and conditioning coaches' doping confrontation efficacy (DCE)
Number of subjects: 822

Group type: EXPERIMENTAL
Intervention: Doping self-regulatory efficacy (SRE)
Number of subjects: 822

Group type: EXPERIMENTAL
Intervention: Doping moral disengagement (MD)
Number of subjects: 822

Group type: EXPERIMENTAL
Intervention: Perceptions of coaches' DCE
Number of subjects: 822

Group type: EXPERIMENTAL
Intervention: Estimated prevalence of intentional doping
Number of subjects: 822
Study: 29045567

Group type: EXPERIMENTAL
Intervention: Individualized PEEP (PEEP IND)
Number of subjects: 50

Group type: COMPARATOR
Intervention: PEEP of 5 cm H 2 O (PEEP 5)
Number of subjects: 50
Study: 25580605

Group type: EXPERIMENTAL
Intervention: Sodium oxybate (SXB) 3 g, 6 g, and 9 g nightly
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 23900468

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA) 2 g daily
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo (2 g corn oil daily)
Number of subjects: 67
Study: 21824456

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 498

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 498

Group type: COMPARATOR
Intervention: Quetiapine
Number of subjects: 498

Group type: COMPARATOR
Intervention: Amisulpride
Number of subjects: 498

Group type: COMPARATOR
Intervention: Ziprasidone
Number of subjects: 498
Study: 19831166

Group type: EXPERIMENTAL
Intervention: Topical application using fingertip
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Topical application using cotton swab
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Topical application using fingertip followed by seven days of brushing
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Topical application using cotton swab followed by seven days of brushing
Number of subjects: 84

Group type: COMPARATOR
Intervention: Comparison between fingertip and cotton swab methods
Number of subjects: 84
Study: 16919207

Group type: EXPERIMENTAL
Intervention: Three cortices fixation (59 patients)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Four cortices fixation (61 patients)
Number of subjects: 120
Study: 14718266

Group type: EXPERIMENTAL
Intervention: Asthma specialist nurse intervention (patient review in a nurse led clinic, liaison with general practitioners and practice nurses, educational outreach, promotion of guidelines for high risk asthma, ongoing clinical support)
Number of subjects: 324

Group type: COMPARATOR
Intervention: Control (standard asthma guidelines promotion and inhaler technique check)
Number of subjects: 324
Study: 11701449

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) administration for 6 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) with ibuprofen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (ibuprofen)
Number of subjects: 0
Study: 9155813

Group type: EXPERIMENTAL
Intervention: Headgear
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Functional appliance
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (observation only)
Number of subjects: 0
Study: 7706589

Group type: EXPERIMENTAL
Intervention: OJ+C (orange juice with additional citrate)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: OJ+M (orange juice with additional malate)
Number of subjects: 16
Study: 3297890

Group type: EXPERIMENTAL
Intervention: Insulin infusion at 34 +/‐ 4 microU/ml
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Insulin infusion at 61 +/‐ 6 microU/ml
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control study (no insulin infusion)
Number of subjects: 10
Study: 31833053

Group type: EXPERIMENTAL
Intervention: Tailored therapies and disease monitoring
Number of subjects: 0

Group type: COMPARATOR
Intervention: Guiding principles of first AML trials
Number of subjects: 0
Study: 30308014

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: LEEP
Number of subjects: 166
Study: 29273021

Group type: EXPERIMENTAL
Intervention: Integrated health promotion intervention (IMPaCT)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Standard community mental health team care (treatment as usual)
Number of subjects: 301
Study: 26230667

Group type: EXPERIMENTAL
Intervention: Lokomat-applied resistance (Loko-R)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Conventional Lokomat-assisted BWSTT (Control)
Number of subjects: 15
Study: 22905857

Group type: EXPERIMENTAL
Intervention: Perampanel 8 mg
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Perampanel 12 mg
Number of subjects: 386

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 386
Study: 21961577

Group type: EXPERIMENTAL
Intervention: 0.5 Gy radiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 2 Gy radiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5 Gy radiation
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0 Gy radiation (control)
Number of subjects: 0
Study: 18211604

Group type: EXPERIMENTAL
Intervention: LPG treatment three times a week for 1 month
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group under medical supervision
Number of subjects: 20
Study: 16595619

Group type: EXPERIMENTAL
Intervention: Comprehensive exercise and lifestyle intervention (supervised moderate-to-high intensity exercise including combined aerobic and weight-training, dietary/health education)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 73
Study: 12943458

Group type: EXPERIMENTAL
Intervention: Natalizumab (3 mg administered in two infusions 4 weeks apart)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 11035656

Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 7788

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7788
Study: 8921922

Group type: EXPERIMENTAL
Intervention: Interviewed by a disabled physician
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Children's pain assessment
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Children's and parent's assessment of pain
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Physical activity if pain disappeared
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Anticipated change in family relationships if pain vanished
Number of subjects: 57
Study: 1560663

Group type: EXPERIMENTAL
Intervention: AMPS program (alcohol misuse prevention curriculum)
Number of subjects: 5000

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 5000
Study: 4013861

Group type: EXPERIMENTAL
Intervention: Smoking one cigarette (0.9mg or 1.5mg standard machine delivery of nicotine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not smoking (NS)
Number of subjects: 0
Study: 31267684

Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg every other day
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Sildenafil 50 mg every other day + l-arginine 3 g/day orally
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control group (sildenafil alone)
Number of subjects: 2
Study: 30154287

Group type: EXPERIMENTAL
Intervention: Clinical pathway group (n=496)
Number of subjects: 862

Group type: COMPARATOR
Intervention: Control group (n=366)
Number of subjects: 862
Study: 27173467

Group type: EXPERIMENTAL
Intervention: Grip strength (measured by dynamometer)
Number of subjects: 1632

Group type: EXPERIMENTAL
Intervention: Arm muscle quality (grip strength divided by arm lean mass)
Number of subjects: 1632

Group type: EXPERIMENTAL
Intervention: Low grip strength (assuming intervention could increase strength by 25%)
Number of subjects: 1632
Study: 24576827

Group type: EXPERIMENTAL
Intervention: Iodine supplementation (1 μg/kg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no iodine supplementation)
Number of subjects: 0
Study: 22876725

Group type: EXPERIMENTAL
Intervention: Soy protein based supplement (G1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Moderate endurance training without supplement (GO)
Number of subjects: 30
Study: 20059766

Group type: EXPERIMENTAL
Intervention: TAXUS Element paclitaxel-eluting stent system
Number of subjects: 0
Study: 19014424

Group type: EXPERIMENTAL
Intervention: Screen-positive groups
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 233
Study: 15958902

Group type: EXPERIMENTAL
Intervention: Percutaneous pin fixation
Number of subjects: 34

Group type: COMPARATOR
Intervention: Cast immobilization
Number of subjects: 34
Study: 12813170

Group type: EXPERIMENTAL
Intervention: Single screening test at age 55
Number of subjects: 42376

Group type: EXPERIMENTAL
Intervention: Screening program with a 4‐year screening interval from age 55 to 67
Number of subjects: 42376

Group type: EXPERIMENTAL
Intervention: Annual screening from age 55 to 67
Number of subjects: 42376

Group type: EXPERIMENTAL
Intervention: Extending annual or quadrennial screening to age 75
Number of subjects: 42376
Study: 10783343

Group type: EXPERIMENTAL
Intervention: decapeptyl-GnRH (100 microgram) daily injected from day 1 to triggering of ovulation
Number of subjects: 230

Group type: COMPARATOR
Intervention: decapeptyl-GnRH (100 microgram) daily injected for the first 7 days
Number of subjects: 230
Study: 8848479

Group type: EXPERIMENTAL
Intervention: 1.08 liters of beer (5.0% ethanol w/v, 1891kJ)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 1.08 liters of light beer (2.9% ethanol w/v, 1197kJ)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 1.08 liters of no‐alcohol beer (0.1% ethanol w/v, 816kJ)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 1.08 liters of cola (1749kJ)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 1.08 liters of carbonated water (0kJ)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Energy from carbohydrate (cola)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Energy from ethanol (beer, light beer, no-alcohol beer)
Number of subjects: 16
Study: 2052097

Group type: EXPERIMENTAL
Intervention: Standard drainage of the thorax (Group I)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Prolonged drainage by 24 hours (Group II)
Number of subjects: 100
Study: 6629637

Group type: EXPERIMENTAL
Intervention: Fenfluramine
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 31013015

Group type: EXPERIMENTAL
Intervention: Mandatory trial registration (after June 2009)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Before mandatory trial registration (January 2007 to May 2009)
Number of subjects: 150
Study: 27758836

Group type: EXPERIMENTAL
Intervention: Adaptive chunking training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Active control intervention
Number of subjects: 30
Study: 25703312

Group type: EXPERIMENTAL
Intervention: High-dose rifampicin (600mg intravenous) plus oral moxifloxacin (400mg or 800mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard-dose rifampicin (450mg oral) plus ethambutol (750mg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Moxifloxacin exposure
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Rifampicin plasma AUC0‐6h
Number of subjects: 60
Study: 24016560

Group type: EXPERIMENTAL
Intervention: Different treatment options for flat type of sudden hearing loss
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Improving inner ear blood rheology and/or reducing blood fibrinogen
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Glucocorticoid treatment
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Combination medication
Number of subjects: 402
Study: 21345841

Group type: EXPERIMENTAL
Intervention: Non-invasive mechanical ventilation (NIV)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Standard medical therapy (SMT)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: NIV
Number of subjects: 82
Study: 19287352

Group type: EXPERIMENTAL
Intervention: Dynamic plate (ABC, study group)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Rigid plate (CSLP, control group)
Number of subjects: 132
Study: 17696854

Group type: EXPERIMENTAL
Intervention: Counseling (5 minutes' duration) regarding house-training
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control group (no counseling)
Number of subjects: 113